- Home
- QGEN vs BRKR Comparison
QGEN vs BRKR Comparison
Compare QGEN & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QGEN | BRKR |
|---|---|---|
| Founded | 1986 | 1960 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 8.1B |
| IPO Year | 1998 | 2000 |
Fundamental Metrics
Financial Performance| Metric | QGEN | BRKR |
|---|---|---|
| Price | $43.84 | $56.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 13 |
| Target Price | $45.76 | ★ $48.54 |
| AVG Volume (30 Days) | 2.2M | ★ 2.4M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 7.17% | 0.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,895,600,000.00 |
| Revenue This Year | $8.18 | $6.30 |
| Revenue Next Year | $5.71 | $3.81 |
| P/E Ratio | $24.01 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.53 | $28.53 |
| 52 Week High | $57.82 | $65.30 |
Technical Indicators
Market Signals| Indicator | QGEN | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 68.74 | 47.79 |
| Support Level | $42.82 | $54.54 |
| Resistance Level | $44.03 | $64.46 |
| Average True Range (ATR) | 0.85 | 3.18 |
| MACD | 0.03 | -1.07 |
| Stochastic Oscillator | 85.92 | 46.37 |
Price Performance
Historical ComparisonAbout QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.